Mostrar el registro sencillo del ítem

dc.contributor.authorGarcía-Ortiz, M.V.
dc.contributor.authorTorre‑Aguilar, M. J. de la
dc.contributor.authorMorales-Ruiz, T.
dc.contributor.authorGómez Fernández, Antonio Rafael
dc.contributor.authorFlores Rojas, Katherine Ubina
dc.contributor.authorGil Campos, Mercedes
dc.contributor.authorMartín-Borreguero, Pilar
dc.contributor.authorAriza, Rafael R.
dc.contributor.authorRoldán-Arjona, Teresa
dc.contributor.authorPérez Navero, Juan Luis
dc.date.accessioned2024-02-12T10:29:21Z
dc.date.available2024-02-12T10:29:21Z
dc.date.issued2021
dc.identifier.urihttp://hdl.handle.net/10396/27424
dc.description.abstractThe goal of this investigation was to determine whether there are alterations in DNA methylation patterns in children with autism spectrum disorder (ASD). Material and Methods: Controlled prospective observational case-control study. Within the ASD group, children were sub-classified based on the presence (AMR subgroup) or absence (ANMR subgroup) of neurodevelopmental regression during the first 2 years of life. We analyzed the global levels of DNA methylation, reflected in LINE-1, and the local DNA methylation pattern in two candidate genes, Neural Cell Adhesion Molecule (NCAM1) and Nerve Growth Factor (NGF) that, according to our previous studies, might be associated to an increased risk for ASD. For this purpose, we utilized blood samples from pediatric patients with ASD (n = 53) and their corresponding controls (n = 45). Results: We observed a slight decrease in methylation levels of LINE-1 in the ASD group, compared to the control group. One of the CpG in LINE-1 (GenBank accession no.X58075, nucleotide position 329) was the main responsible for such reduction, highly significant in the ASD subgroup of children with AMR (p < 0.05). Furthermore, we detected higher NCAM1 methylation levels in ASD children, compared to healthy children (p < 0.001). The data, moreover, showed higher NGF methylation levels in the AMR subgroup, compared to the control group and the ANMR subgroup. These results are consistent with our prior study, in which lower plasma levels of NCAM1 and higher levels of NGF were found in the ANMR subgroup, compared to the subgroup that comprised neurotypically developing children. Conclusions: We have provided new clues about the epigenetic changes that occur in ASD, and suggest two potential epigenetic biomarkers that would facilitate the diagnosis of the disorder. We similarly present with evidence of a clear differentiation in DNA methylation between the ASD subgroups, with or without mental regression.es_ES
dc.format.mimetypeapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherFrontierses_ES
dc.rightshttps://creativecommons.org/licenses/by/4.0/es_ES
dc.sourceGarcía-Ortiz MV, Torre-Aguilar MJ, Morales-Ruiz T, Gómez-Fernández A, Flores-Rojas K, Gil-Campos M, Martin-Borreguero P, Ariza RR, Roldán-Arjona T and Perez-Navero JL (2021) Analysis of Global and Local DNA Methylation Patterns in Blood Samples of Patients With Autism Spectrum Disorder. Front. Pediatr. 9:685310. doi: 10.3389/fped.2021.685310es_ES
dc.subjectAutism spectrum disorderes_ES
dc.subjectNeurodevelopmental regressiones_ES
dc.subjectDNA methylation patternses_ES
dc.subjectNCAMes_ES
dc.subjectNGFes_ES
dc.titleAnalysis of Global and Local DNA Methylation Patterns in Blood Samples of Patients With Autism Spectrum Disorderes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversionhttp://dx.doi.org/10.3389/fped.2021.685310es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem